"The government has created a PDF for CLMV countries to facilitate Indian investment and broaden manufacturing base of Indian companies in the region," Commerce and Industry Minister Nirmala Sitharaman said in a written reply to the Rajya Sabha.
Replying to a separate question, she said section 3 (d) of the Indian Patent Act, 1970 is complaint to WTO norms and there is no evidence to show that this norm restrains innovation.
Multi-national companies particularly in the pharma sector have alleged that this section restricts innovation.
She also said that it was informed to SME Pharma Industries Confederation (India) that the bar code on drugs and pharmaceuticals meant for exports only.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
